Geode Capital Management, LLC Recursion Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 7,776,408 shares of RXRX stock, worth $42.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,776,408

Previous 6,443,980 20.68%

Holding current value

$42.1 Million

Previous $34.1 Million 15.43%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$3.97 - $5.84 $5.29 Million - $7.78 Million	1,332,428 Added 20.68%	7,776,408 $39.3 Million
Q1 2025 May 13, 2025	BUY	$5.29 - $10.87 $1.89 Million - $3.88 Million	356,831 Added 5.86%	6,443,980 $34.1 Million
Q4 2024 Feb 12, 2025	BUY	$5.7 - $8.27 $3.73 Million - $5.42 Million	655,238 Added 12.06%	6,087,149 $41.1 Million
Q3 2024 Nov 12, 2024	BUY	$5.92 - $8.6 $3.88 Million - $5.64 Million	656,003 Added 13.74%	5,431,911 $35.8 Million
Q2 2024 Aug 09, 2024	BUY	$7.35 - $10.05 $9.74 Million - $13.3 Million	1,324,743 Added 38.39%	4,775,908 $35.8 Million
Q1 2024 May 13, 2024	BUY	$9.13 - $15.52 $1.14 Million - $1.94 Million	125,180 Added 3.76%	3,451,165 $34.4 Million
Q4 2023 Feb 13, 2024	BUY	$5.09 - $10.79 $953,331 - $2.02 Million	187,295 Added 5.97%	3,325,985 $32.8 Million
Q3 2023 Nov 13, 2023	BUY	$6.59 - $15.86 $2.17 Million - $5.23 Million	329,547 Added 11.73%	3,138,690 $24 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $299,405 - $652,650	65,659 Added 2.39%	2,809,143 $21 Million
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $857,301 - $1.29 Million	133,536 Added 5.12%	2,743,484 $18.3 Million
Q4 2022 Feb 13, 2023	BUY	$7.16 - $12.7 $1.99 Million - $3.53 Million	277,865 Added 11.91%	2,609,948 $20.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $6.47 Million - $11.2 Million	826,087 Added 54.85%	2,332,083 $24.8 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $1.07 Million - $1.97 Million	212,240 Added 16.4%	1,505,996 $12.3 Million
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $7,398 - $21,654	-1,201 Reduced 0.09%	1,293,756 $9.26 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $11.8 Million - $16 Million	732,626 Added 130.28%	1,294,957 $22.2 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $1.24 Million - $2.7 Million	65,382 Added 13.16%	562,331 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $8.95 Million - $18.6 Million	496,949 New	496,949 $18.1 Million

Others Institutions Holding RXRX

# of Institutions

367

Shares Held

288M

Call Options Held

7.76M

Put Options Held

6.19M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $976M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Recursion Pharmaceuticals, Inc. Transaction History